Investing Profile
Robert Kamen
Your Intro Paths to Robert Kamen
Signal uses Gmail to reveal intro paths. Email content is never read.
Sign in with Google →Networks Robert is a member of
Amherst College Network
25 CONNECTIONS
Find Robert Kamen on
cbCurrent Investing Position
Third Rock Ventures Venture Partner
Investment Range
$100K - $1.5M
Sweet Spot
$1.5M
Current Fund Size
$770M
Robert Kamen is on these Sector & Stage Rankings
Robert Kamen's Experience
Advisory Partner Third Rock Ventures2022 - Present
Member Board of Directors HBM Alpha Therapetics2020 - Present
Member Board of Directors HARBOUR BIOMED2016 - Present
Board Member EpimAb Biotherapeutics, Inc.2015 - Present
Board of Directors Jounce Therapeutics2013 - Present
Venture Partner Third Rock Ventures2018 - 2021
Board Member Neon Therapeutics2015 - 2020
Board Member Sudbury Valley Trustees Inc2006 - 2020
Board of Directors Lycera2009 - 2019
Entrepreneur In Residence Third Rock Ventures2010 - 2017
Board Member Harbour Antibodies2007 - 2016
Board of Directors Opsonic Therapeutics2010 - 2014
Managing Director Velocon Sports, Inc2007 - 2014
Board of Directors Anchor Therapeutics2010 - 2012
Biopharm Investment Board GlaxoSmithKline2009 - 2011
Chairman of the Board BioAssets Development Corporation2005 - 2010
Executive in Residence Oxford Bioscience Partners2002 - 2008
President Abbott Bioresearch Center, Abbott Laboratories2001 - 2002
President BASF Bioresearch Corporation1991 - 2001
Board Member Massachusetts Biomedical Initiatives (MBI)1993 - 1998
Visiting Scientist Whitehead Institute for Biomedical Research1989 - 1990
Senior VP Scientific Affairs Genetics Institute, Inc1982 - 1989
Head, Transcription Laboratory Imperial Cancer Research Fund Laboratories1976 - 1982
Robert Kamen's Education
Imperial Cancer Research Fund Laboratories (London) DNA Tumor Viruses
Universität Zürich (Switzerland) Biochemistry and Molecular Biology
Harvard University Graduate School of Arts and Sciences Ph.D. Biochemistry and Molecular Biology
Amherst College A.B. Biophysics